Nil A. Schubert
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 20, 2021
Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 02, 2021
High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells.
Journal: Molecular cancer therapeutics
Published: August 05, 2020
Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 04, 2020
Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 31, 2019
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
Journal: Neuro-oncology
Published: May 09, 2017
Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility.
Journal: PLoS genetics
Published: June 12, 2015
HNA antibody-mediated neutrophil aggregation is dependent on serine protease activity.
Journal: Vox sanguinis
Published: December 29, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026